Search
LES FUNTLEYDER
Related Articles
Bankers-Turned-CEOs Fight for Elan in Year’s Top Hostile Bid
4 days ago
Prudential Takes On Aflac in Benefits After Health Law
1 months ago
Biotechnology Draws Record Profit as Research Money Slows
2 months ago
Tip to Wall Street on Medicare Rates Draws Scrutiny
2 months ago
Theravance Seen Luring Glaxo Bid as Drugs Near FDA Nod: Real M&A
3 months ago
Puma Biotechnology Priced Like Takeover Target: Real M&A
3 months ago
Pfizer Breakup Talk Stoked by Discount to Drug Stocks
4 months ago
Berkshire Adding DaVita Makes Pick Among Top at Firm
6 months ago
Tech Workers See Opportunity as Health-Care Law Kicks In
7 months ago
LabCorp Seen Luring Buyout Before Health-Care Revamp
10 months ago
Funtleyder, Brusuelas, Willis Discuss Health Care (Audio)
12 months ago
Express Scripts’ Medco Deal May Be Delayed by Potential Suit
15 months ago
Express Scripts’ Medco Deal May Be Delayed by Potential Suit
15 months ago
Bayer Said to Consider Bid for Pfizer Animal-Health Unit
16 months ago
Obesity Prompts Vivus Takeover Talk With 88% Windfall: Real M&A
16 months ago
Roche’s Bid for Illumina May Spur Deals as DNA Tests Reach Doctor’s Office
17 months ago
Icahn’s $2 Billion Man Starts Fund as Activists Shun Biotech
19 months ago
Bristol Diabetes Pill Faces Safety Hurdle After Early Drugs Tied to Risks
24 months ago
Pfizer Said to Pay $330 Million to Settle Prempro Lawsuits Claiming Cancer
29 months ago
Pfizer CEO Kindler Resigns After Stock Underperforms 97 Percent of S&P 500
31 months ago
Show More News